GHRP-2 (10MG)

Additional Info

Properties

• Chemical Formula: C45H55N9O6
• Molecular Weight: 817.9 g/mol
• Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
• Total Amount: 10mg (1 vial)
• Shelf Life: 36 months

Shipping

We ship to the USA and Canada. For international orders that are seized, a 50% discount applicable on your next purchase will be provided. Please contact us for more information.

Disclaimer

The information provided does not replace medical advice, diagnosis, or treatment. If you have concerns about a medical condition, consult your physician or a qualified healthcare provider promptly. Never delay seeking medical advice due to information you have read or seen. We assume no responsibility or liability for the use of our research compounds and products, which are strictly intended for research purposes. These products are not approved by the FDA for human consumption.

Additional Label & Product Information

Essential Warning:

• These chemicals are for research or laboratory use only.

Instructions for Use:

• Avoid contact with skin and eyes. In case of contact, rinse immediately with plenty of water.
• Seek medical advice if you feel unwell or accidentally ingest the product.
• Store the lyophilized (freeze-dried) peptide at room temperature upon receipt to maintain stability. Avoid frequent freeze-thaw cycles.

Product Disclaimer:

• This product is not intended to diagnose, treat, cure, or prevent any disease. Use only as specified by your research or laboratory protocol.

Resources

1. Phung LT et al. investigated the impact of growth hormone-releasing peptide-2 (GHRP-2) on growth hormone release and growth performance in swine. Their findings were published in the journal Domestic Animal Endocrinology in April 2000.
2. Laferrère B et al. conducted a study demonstrating that growth hormone releasing peptide-2 (GHRP-2) increases food intake in healthy men. This research was published in The Journal of Clinical Endocrinology & Metabolism in February 2005.
3. Hu R et al. explored the effects of GHRP-2 and cysteamine on growth performance, somatotropic hormone axis, and muscle protein deposition in yaks with growth retardation. Their study was published in PLOS ONE in February 2016.
4. Titterington JS et al. found that GHRP-2 suppresses vascular oxidative stress in mice lacking ApoE, although it did not reduce atherosclerosis. Their research was published in Endocrinology in December 2009.
5. Chao YN et al. investigated how GHRP-2 reduces inflammation induced by protein kinase C in human ovarian granulosa cells. Their findings were published in International Journal of Molecular Sciences in August 2016.
6. Zeng P et al. discovered that GHRP-2, a ghrelin receptor agonist, produces antinociceptive effects at the supraspinal level via opioid receptors in mice. Their study was published in Peptides in May 2014.
7. Sigalos JT and Pastuszak AW reviewed the safety and efficacy of growth hormone secretagogues, including GHRP-2, in their article published in Sexual Medicine Reviews in January 2018.